The COVID Advisor

If you are confused about the recommendations made by different professional groups for the COVID-19 pandemic, you've come to the right place.  The U.S. Centers for Disease Control and Prevention (CDC) said that COVID-19 levels across the United States are currently “very high” in more than half of the states, with Omicron variant KP.3.1.1 accounting for about half of all cases; for the two-week period ending September 14, 2024 ( source ). A spokesperson for the CDC told The Epoch Times that the KP.3.1.1 “is very similar to other circulating variants in the United States, and all current lineages are descendants of JN.1, which emerged in late 2023.” Some media outlets have referred to both the KP.2 and KP.3 variants as “FLiRT,” (which stands for mutations in the virus's spike protein at positions designated "F for L" and "R for T"). Are the current treatment options still relevant? The number of options for the treatment of COVID-19 has increa

A new COVID-19 variant called XEC has begun to spread in multiple regions worldwide and the U.S. Centers for Disease Control and Prevention (CDC) said that no specific symptoms are associated with the variant. The variant first appeared in Berlin in late June and has spread across Germany, France, Denmark, and Netherlands, said a report from data integration specialist Mike Honey, citing the Global Initiative on Sharing All Influenza Data. CDC spokeswoman Rosa Norman told The Epoch Times on Monday that the CDC is monitoring “the emergence of variants in the population,” including XEC, and that “specific cases cannot be associated with specific variants.” “Please continue to check the COVID Data Tracker for updated information on the common variants we’re seeing the U.S,” she said. Symptoms When asked whether XEC may produce different or more severe symptoms, Norman said the CDC is not aware of any “specific symptoms” associated with the variant or “co-circulating” strains. A global he

Rationale for Risk Stratification We continue to observe COVID-19 vaccinated persons suffer cardiac arrests since the inception of the mass vaccination campaign in late 2020 [1–5]. Figure 1 illustrates the likely mechanisms. Both Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273) mRNA have been found in human heart muscle at autopsy [6]. Spike protein has been stained in endomyocardial biopsy samples of young men suffering from COVID-19 vaccine-induced myocarditis [7]. Victims have been found to have circulating Spike protein but ineffective antibodies, likely IgG4 subclass, that fail to neutralize Spike protein and allow its assault on the heart [8]. Positron emission tomography data have revealed a shift from free fatty acid metabolism to glucose metabolism in the hearts of the majority of individuals who have received a COVID-19 vaccine. [9]. The PET pattern resembles global ischemia. This could be due to vaccine Spike protein hemagglutination in myocardial capillaries or cellular c

As of September 2024, there are  more than 4,000 studies  published related to the treatment and prevention of COVID-19. If you are still confused about the recommendations made by different professional groups for the COVID-19 pandemic, you've come to the right place. The number of options for the treatment of COVID-19 has increased drastically in recent months, thus making it complicated when it comes to choosing the right combination. In general, there are 3 broad categories of medical interventions: Prevention or Prophylaxis e.g. vaccine Early out-patient treatment Hospital treatment The various treatments available for different conditions often involve the use of complex technologies and specialized terminology, which can be overwhelming and confusing for consumers. To achieve the best possible outcome, multiple treatments and strategies are typically used in combination. Therefore, it's important to work closely with your healthcare provider to understand the different o